from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0287/esxG

LFCtreatmentdescriptionclass of inhibitor

-1.979

Amikacinug/mL Amikacintranslation

-2.740

Cap5-10ug/mL Capreomycintranslation

-2.996

Rox10-50 ug/mL Roxithromycintranslation

-0.779

SM2-5 ug/mL Streptomycintranslation

-2.866

Tet5-10 ug/mL Tetracyclinetranslation

0.105

Rif0.2-5ug/mL Rifampicintranscription

-1.005

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.777

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.209

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.020

CPZ10-50 ug/mL Chlorpromazinerespiration

2.260

Clofazimine10-13 ug/mL Clofaziminerespiration

0.019

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.198

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.316

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.504

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.146

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.931

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.041

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.313

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.062

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.315

KCN5-20 ug/mL Potassium cyaniderespiration

-0.097

NaN30.2-2 mM Sodium aziderespiration

-0.190

Nigericin50 uM Nigericinrespiration

-0.019

TRC10-150 ug/mL Triclosanrespiration

-0.269

TRZ10-25 ug/mL Thioridazinerespiration

-1.299

Valinomycin0.5-10 uM Valinomycinrespiration

-0.795

ZnSO42 mM ZnSO4respiration

-0.709

menadione6-10 ug/mL Menadionerespiration

2.032

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.576

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

2.139

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.448

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.075

NRP_1Non-replicating persistence stage 1dosRassociated

0.403

Amp0.2mg/mL AmpicillincellWall

0.408

Cephalexin20-100 ug/mL CephalexincellWall

0.755

Cerulenin0.32-5 ug/mL CerulenincellWall

0.695

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.855

EMB10-20 ug/mL EthambutolcellWall

0.611

Eta12-40 ug/mL EthionamidecellWall

0.918

INH0.2-0.4 ug/mL IsoniazidcellWall

0.636

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.284

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.297

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.359

BZA0.12 mg/mL BenzamidearomaticAmides

-0.237

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.069

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.032

H2O24 mM hydrogen peroxideDNAdamaging

-1.169

Levo10 ug/mL LevofloxacinDNAdamaging

0.058

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.622

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.207

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.014

UVUV-irradiationDNAdamaging

-0.033

ARP41-4 ug/mL Antitubercular compound ARP4?

0.399

Antimycin12.5-50 ug/mL Antimycin A?

0.435

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.682

PA_110-50 ug/mL Antitubercular compound PA-1?

0.511

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.527

PA8240.2-2 ug/mL PA-824?

-1.104

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.087

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.432

Verapamil50 uM Verapamil?

0.543

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.056

methoxatin10-20 ug/mL Methoxatin?